{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:35:18Z","timestamp":1792157718431,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.humpath.2025.105926","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:35:20Z","timestamp":1756794920000},"page":"105926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Assessment of Nectin4-expression in vulvar squamous cell carcinomas (VSCC): correlation with HPV-associated and HPV-independent molecular subtypes"],"prefix":"10.1016","volume":"164","author":[{"given":"Anne Kathrin","family":"H\u00f6hn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit Gesine Ruth","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Forberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Brambs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Christian","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105926_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2025.105926_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/his.13989","article-title":"Vulval squamous cell carcinoma and its precursors","volume":"76","author":"Singh","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105926_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100145","article-title":"Classification of vulvar squamous cell carcinoma and precursor lesions by p16 and p53 immunohistochemistry: considerations, caveats, and an algorithmic approach","volume":"36","author":"Yang","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105926_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11041025","article-title":"Squamous cell carcinoma of the vulva: a survival and epidemiologic study with focus on surgery and radiotherapy","volume":"11","author":"Scampa","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.humpath.2025.105926_bib5","article-title":"Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma","author":"Davidson","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.105926_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.semdp.2020.09.004","article-title":"A review of prognostic factors in squamous cell carcinoma of the vulva: evidence from the last decade","volume":"38","author":"Julia","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2025.105926_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2020.09.024","article-title":"Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes","volume":"159","author":"Kortekaas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2025.105926_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/ijgc-2021-003251","article-title":"Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique","volume":"32","author":"Thompson","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2025.105926_bib9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/his.14860","article-title":"Vulvar squamous cell carcinoma arising on human papillomavirus-independent precursors mimicking high-grade squamous intra-epithelial lesion: a distinct and highly recurrent subtype of vulvar cancer","volume":"82","author":"Carreras-Dieguez","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105926_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/aogs.14689","article-title":"TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma","volume":"103","author":"Dongre","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.humpath.2025.105926_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244216","article-title":"Molecular subtypes of vulvar squamous cell carcinoma: the significance of HPV-Independent\/p53 wild type","volume":"16","author":"Horn","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2025.105926_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/PGP.0000000000000950","article-title":"The genomic landscape of vulvar squamous cell carcinoma","volume":"42","author":"Corey","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2025.105926_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(18)30109-8","article-title":"Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial","volume":"19","author":"H\u00f6ckel","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2025.105926_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/ijgc-2019-000793","article-title":"Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma","volume":"30","author":"Proctor","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2025.105926_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1352975","article-title":"Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis","volume":"14","author":"Schwab","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2025.105926_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12062172","article-title":"Trends in net survival from vulvar squamous cell carcinoma in Italy (1990-2015)","volume":"12","author":"Mancini","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.humpath.2025.105926_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/GCO.0000000000001002","article-title":"Antibody-drug conjugates as targeted therapy for treating gynecologic cancers: update 2025","volume":"37","author":"Silverstein","year":"2025","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.humpath.2025.105926_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pathol.2022.11.004","article-title":"The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma","volume":"55","author":"Talia","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2025.105926_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/ijgc-2022-003701","article-title":"Integrating antibody drug conjugates in the management of gynecologic cancers","volume":"33","author":"Chelariu-Raicu","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2025.105926_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1470-2045(18)30859-3","article-title":"Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial","volume":"20","author":"Bono","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2025.105926_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab vedotin in previously treated advanced urothelial carcinoma","volume":"384","author":"Powles","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105926_bib22","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/1078-0432.CCR-22-1764","article-title":"Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with Enfortumab vedotin resistance","volume":"29","author":"Kl\u00fcmper","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105926_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1158\/1535-7163.MCT-21-0846","article-title":"The anti-nectin 4: a promising tumor cells target. A systematic review","volume":"21","author":"Bouleftour","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.humpath.2025.105926_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0b013e31826916c7","article-title":"The lower anogenital squamous Terminology standardization project for HPV-associated lesions: background and consensus recommendations from the college of American Pathologists and the American society for colposcopy and cervical Pathology","volume":"32","author":"Darragh","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2025.105926_bib25","series-title":"Final-BAGP-UKNEQAS-cIQC-project-p16-interpretation-guide-2018","author":"Singh","year":"2018"},{"key":"10.1016\/j.humpath.2025.105926_bib26","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105926_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/his.14109","article-title":"Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma","volume":"77","author":"Kortekaas","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105926_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2024.02.001","article-title":"High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostaining","volume":"185","author":"H\u00f6hn","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2025.105926_bib29","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.18632\/oncotarget.28299","article-title":"Nectin-4 is widely expressed in head and neck squamous cell carcinoma","volume":"13","author":"Sanders","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2025.105926_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.humpath.2023.10.003","article-title":"Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma","volume":"142","author":"Tekin","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105926_bib31","first-page":"1","article-title":"Trop2 expression in correlation to the molecular subtype in vulvar squamous cell carcinomas","author":"H\u00f6hn","year":"2025","journal-title":"Pathobiology"},{"key":"10.1016\/j.humpath.2025.105926_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2022.12.008","article-title":"An analysis of nectin-4 (PVRL4) in penile squamous cell carcinoma","volume":"49","author":"Grass","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.humpath.2025.105926_bib33","series-title":"Contributed packages","author":"Ogle","year":"2015"},{"key":"10.1016\/j.humpath.2025.105926_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.07.007","article-title":"Risk factors and treatment for recurrent vulvar squamous cell carcinoma","volume":"106","author":"Nooij","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.humpath.2025.105926_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16040770","article-title":"Recent therapeutic advances in gynecologic oncology: a review","volume":"16","author":"Wilson","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2025.105926_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122910","article-title":"Nectin-4-directed antibody-drug conjugates (ADCs): spotlight on preclinical and clinical evidence","volume":"352","author":"Khosravanian","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.humpath.2025.105926_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215969","article-title":"Drug conjugate-based anticancer therapy - current status and perspectives","volume":"552","author":"Yang","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humpath.2025.105926_bib38","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1007\/s00432-023-04761-8","article-title":"TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target","volume":"149","author":"Condic","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105926_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216109","article-title":"Metastatic penile squamous cell carcinoma responsive to Enfortumab vedotin","volume":"24","author":"Fahey","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2025.105926_bib40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/his.15130","article-title":"Associations of TACSTD2\/TROP2 and NECTIN-4\/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts","volume":"84","author":"Bahlinger","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105926_bib41","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.annonc.2021.02.017","article-title":"Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I","volume":"32","author":"Moore","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2025.105926_bib42","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1200\/JCO.22.01900","article-title":"Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: results from the SORAYA study","volume":"41","author":"Matulonis","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105926_bib43","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1158\/1078-0432.CCR-23-0991","article-title":"FDA approval summary: mirvetuximab soravtansine-Gynx for FR\u03b1-positive, platinum-resistant ovarian cancer","volume":"29","author":"Dilawari","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105926_bib44","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038132","article-title":"Mirvetuximab soravtansine: a breakthrough in targeted therapy for platinum-resistant ovarian cancer","volume":"103","author":"Kokori","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.humpath.2025.105926_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154072","article-title":"Tumor expression of Nectin-1-4 and its clinical implication in muscle invasive bladder cancer: an intra-patient variability of Nectin-4 expression","volume":"237","author":"Miyake","year":"2022","journal-title":"Pathol Res Pract"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T17:54:29Z","timestamp":1759859669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"alternative-id":["S0046817725002138"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105926","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Nectin4-expression in vulvar squamous cell carcinomas (VSCC): correlation with HPV-associated and HPV-independent molecular subtypes","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105926"}}